The Use of Ibrutinib in Extranodal Marginal Zone Lymphoma of the Ocular Adnexa with Multifocal Disease that is Refractory to Rituximab. Translation [Internet]. 2024 Jul. 31 [cited 2026 Jul. 27];12(5). Available from: https://dev.openjournals.utoledo.edu/index.php/translation/article/view/626